Legacy Capital Group California, Inc. Becton Dickinson & CO Transaction History

Legacy Capital Group California, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	BUY	$232.24 - $267.23 $11,844 - $13,628	51 Added 2.34%	2,235 $545 Million
Q3 2023 Nov 06, 2023	SELL	$254.9 - $283.59 $66,783 - $74,300	-262 Reduced 10.71%	2,184 $565 Million
Q2 2023 Aug 10, 2023	BUY	$238.39 - $265.32 $118,241 - $131,598	496 Added 25.44%	2,446 $646 Million
Q1 2023 May 11, 2023	BUY	$229.71 - $259.35 $447,934 - $505,732	1,950 New	1,950 $483 Million

1,737

250M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $63.3B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Legacy Capital Group California, Inc., based on Form 13F filings with the SEC.

Stay updated on Legacy Capital Group California, Inc. with notifications on news.